ArticleInternational journal of hematology2010

Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma: the collaborative study at six institutes in Kyoto and Osaka.

Tsutomu Kobayashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.